VIP, vasoactive intestinal peptide, 7432

N. diseases: 376; N. variants: 2
Disease: Neoplasm Metastasis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.320 Biomarker phenotype BEFREE Vasoactive intestinal peptide-secreting tumors (VIPomas) are rare functioning neuroendocrine tumors often characterized by a difficult-to-control secretory syndrome and high potential to develop metastases. 31268974 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.320 Biomarker phenotype CTD_human Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells. 19189304 2009
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.320 Biomarker phenotype BEFREE VIP binding has been demonstrated on many tumor types, and radiolabeled VIP has recently been used as a novel method to localize intestinal tumors in humans and their sites of metastasis. 7600524 1995